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Abstract 
Background: Dengue and malaria are two common, mosquito-borne infections, which may lead to mortality if not 
managed properly. Concurrent infections of dengue and malaria are rare due to the different habitats of its vectors 
and activities of different carrier mosquitoes. The first case reported was in 2005. Since then, several concurrent infec-
tions have been reported between the dengue virus (DENV) and the malaria protozoans, Plasmodium falciparum and 
Plasmodium vivax. Symptoms of each infection may be masked by a simultaneous second infection, resulting in late 
treatment and severe complications. Plasmodium knowlesi is also a common cause of malaria in Malaysia with one of 
the highest rates of mortality. This report is one of the earliest in literature of concomitant infection between DENV 
and P. knowlesi in which a delay in diagnosis had placed a patient in a life-threatening situation.
Case presentation: A 59-year old man staying near the Belum-Temengor rainforest at the Malaysia–Thailand border 
was admitted with fever for 6 days, with respiratory distress. His non-structural protein 1 antigen and Anti-DENV 
Immunoglobulin M tests were positive. He was treated for severe dengue with compensated shock. Treating the 
dengue had so distracted the clinicians that a blood film for the malaria parasite was not done. Despite aggressive 
supportive treatment in the intensive care unit (ICU), the patient had unresolved acidosis as well as multi-organ 
failure involving respiratory, renal, liver, and haematological systems. It was due to the presentation of shivering in the 
ICU, that a blood film was done on the second day that revealed the presence of P. knowlesi with a parasite count of 
520,000/μL. The patient was subsequently treated with artesunate-doxycycline and made a good recovery after nine 
days in ICU.
Conclusions: This case contributes to the body of literature on co-infection between DENV and P. knowlesi and high-
lights the clinical consequences, which can be severe. Awareness should be raised among health-care workers on the 
possibility of dengue-malaria co-infection in this region. Further research is required to determine the real incidence 
and risk of co-infection in order to improve the management of acute febrile illness.
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Background
Dengue and malaria are two common mosquito-borne 
diseases in tropical countries, which are potentially 
fatal. Dengue is a viral disease transmitted by the ‘urban 
mosquito’ Aedes aegypti. The estimated global incidence 
of dengue is 390 million a year with about 96 million 
cases manifesting clinically [1]. Malaria is a protozoan 
disease transmitted by the ‘jungle mosquito’ Anoph-
eles species. The World Health Organization (WHO) 
estimated that 214 million malaria infections occurred 
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Dengue fever can occur simultaneously with other 
virus, bacteria and protozoa infection [3–5]. Since the 
first reported case of dengue-malaria co-infection in 
France in 2005 [6], more cases have been reported in 
India [7, 8], Pakistan [9, 10], Brazil [11], East Timor [12], 
Bangladesh [13], Indonesia [14], Cambodia [15], Malaysia 
[16], and Japan [17]. Among these reported cases, only 
Plasmodium falciparum and Plasmodium vivax were 
involved. This case involved a concurrent infection of 
dengue virus (DENV) and Plasmodium knowlesi, which 
had misled clinicians resulting in delayed treatment with 
life-threatening consequences.
Case report
The patient was a 59-year-old man from the town of Jeli 
in Malaysia. Jeli lies on the edge of the Belum-Temengor 
rainforest, one of Malaysia’s national reserves bordering 
Thailand. Gradual urbanization over the past few dec-
ades has made this town an outbreak area of dengue and 
leptospirosis.
The patient was admitted with fever, headache, myal-
gia, arthralgia, and poor oral intake over the 6 days prior 
to admission. He was given antipyretic and amoxicillin by 
his general practitioner, but his condition had worsened. 
No blood investigation was done. On the day of presen-
tation, he had difficulty in breathing and was referred to 
hospital.
At the emergency department, the patient was con-
scious but lethargic. He was mildly dehydrated, blood 
pressure (BP) was 102/78  mmHg and heart rate was 
104  bpm. Capillary refill time was less than 2  s with a 
high, spiking temperature of 40  °C. He was mildly jaun-
diced and abdomen was soft with no organomegaly. 
There were no signs of haemorrhagic manifestation. 
Respiratory rate was 35 breaths/min and oxygen satura-
tion (SPO2) was 93% on ambient air. Lungs were clear 
and breath sounds were equal bilaterally. He had type I 
respiratory failure, with arterial blood gas (ABG) pH of 
7.36, PaCO2 at 25.6 mm Hg, PaO2 at 77.4 mm Hg, bicar-
bonate at 21.2 mmol/L, and lactate at 1.8 mmol/L on face 
mask oxygen of 5 L/min. Non-invasive ventilatory (NIV) 
support was required to improve oxygenation. Bedside 
abdominal ultrasonography performed showed no hepat-
osplenomegaly with a normal biliary tract. Inferior vena 
cava (IVC) was collapsed at 0.88  cm, with a collapsibil-
ity index of more than 50%. Fluid challenge with normal 
saline was initiated and titrated up to 10 mL/kg/h.
Investigations done in the emergency department 
revealed a platelet count of 33  ×  109/L and a haema-
tocrit (HCT) level of 39.4%. A rapid test using immu-
nochromatic technique (ICT) was positive for dengue 
non-structural protein1 (NS1) antigen; similarly, the 
serologic Anti-DENV Immunoglobulin M (IgM) testing. 
International normalized ratio (INR) was 1.23 and 
aPTT was 44.3 s. Other laboratory investigation results 
included: haemoglobin (14.3 g/dL), red blood cell (RBC) 
count (4.55  ×  1012/L) and white blood cell (WBC) 
count (6.91  ×  109/L). Hyponatraemia (131  mmol/L) 
was present and liver function test was deranged with 
a total bilirubin of 46  mmol/L, alanine transferase of 
77  mmol/L and alkaline phosphatase of 151  mmol/L 
(Table  1). A blood film for malaria parasites was not 
carried out.
The patient was diagnosed as a severe dengue case and 
admitted to the intensive care unit (ICU) for closer obser-
vation. Bedside echocardiography revealed a normal car-
diac function and IVC had picked up to 1.9 cm with the 
collapsibility index reduced to less than 50%, which cor-
responded to an improved volume status. However, the 
serum lactate level was still increasing, acidosis worsen-
ing and urine output decreasing. Further fluid challenge 
was administered carefully up to 50 mL/kg over 8 h with 
regular IVC assessment. Intravenous ceftriaxone, 2  g 
daily, was initiated by the physician to cover the possibil-
ity of concomitant leptospirosis because the patient was 
from an outbreak area.
On the following day, the patient’s oxygenation dete-
riorated and NIV support had to be increased gradually. 
Under an FiO2 of 60%, ABG showed: pH 7.247, pCO2 
30.4  mmHg, pO2 100  mmHg, HCO3 16.1  mmol/L and 
lactate 3.5 mmol/L. A chest radiograph repeated the fol-
lowing day showed the presence of perihilar haziness and 
increased pulmonary vascular markings (Fig.  1b). The 
patient’s platelet counts dropped further to 17  ×  109/L 
but there was no sign of spontaneous bleeding. He also 
went through a few hypotensive episodes where the BP 
dropped to 85/50  mmHg and mean arterial pressure 
down to 60  mmHg. Vasopressor had to be initiated to 
maintain a mean arterial pressure of above 65  mmHg. 
Meanwhile, he suffered acute kidney injury with a urine 
output of 5–10 mL/h, requiring haemodialysis. Although 
it was the seventh day of illness (second day from admis-
sion), the patient had a spiking temperature of 38.7  °C. 
The fever was preceded by severe shivering which lasted 
for nearly an hour. This shivering led clinicians to per-
form a blood film for malaria parasite (BFMP). The result 
showed the presence of the malaria parasite resembling 
Plasmodium knowlesi with parasitaemia of 520,000/µL 
of blood. Intravenous artesunate 2.4  mg/kg daily and 
doxycycline 100  mg twice a day were started. Subse-
quently, polymerase chain reaction (PCR) test confirmed 
the parasite to be P. knowlesi. Soon after starting anti-
malarial treatment, the malaria parasite count dropped 
to 460,000/μL after 24  h and 320/μL after 48  h, respec-
tively. The patient’s platelet count started to improve as 
well (Table 1).
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On the sixth day from admission, the patient’s res-
piratory symptoms worsened again with coarse crack-
les heard over both lungs on auscultation. He required 
NIV support to maintain an SPO2 of more than 92%. 
From ABG, PaO2 was 80 mmHg with FiO2 of 60%. Chest 
radiography showed increased air-space opacity in both 
lungs and parapneumonic effusion (Fig.  1c). His WBC 
count raised to 17.4 ×  109/L with predominant neutro-
philia, and C-reactive protein was more than 200 mg/L. 
He was then treated for hospital-acquired pneumonia 
with acute respiratory distress syndrome (ARDS). Intra-
venous meropenam was initiated.
With close monitoring and vigilant treatment, the 
patient’s condition improved. His oxygenation, renal 
function, liver function, and platelet count returned to 
normal. He was successfully weaned off NIV support on 
the eighth day from admission. Blood and urine cultures 
all yielded negative results. Serology for leptospirosis, 
syphilis, hepatitis B, hepatitis C and HIV screenings were 
negative. Parasites were cleared from his blood on the 
eighth day after starting artesunate and doxycycline. He 
was finally able to be transferred to the general ward, and 
was discharged on the 15th day of hospitalization (refer 
Fig.  2 for event timeline). On subsequent follow-up the 
Table 1 Laboratory findings and progress
ABG arterial blood gas, aPTT activated partial thromboplastin time, BIPAP bilevel positive airway pressure, CPAP continuous positive airway pressure, CRP C-reactive 
protein, FMO2 face mask oxygen, IgM immunoglobulin M, INR international normalized ratio, NS1 nonstructural protein 1, PaCO2 partial pressure of carbon dioxide, 
PaO2 partial pressure of oxygen
Investigations Normal range Day 1 (of admission) Day 2 Day 3 Day 4 Day 6 Day 9
Parasite counts (/µL) – 520,000 460,000 320 120 Nil
Haemoglobin (g/dL) [13.5–17.5] 14.3 11.8 11.4 8.8 10.2 9.1
Platelet count (×109/L) [150–450] 33 17 20 78 175 277
Haematocrit (%) [42–54] 39.4 32.8 32.1 24.4 28.2 26.5
White blood cell count 
(×109/L)
[4000–11,000] 6.91 6.87 9.21 10.97 17.39 9.25
Red blood cells (×1012/L) [4, 5] 4.55 3.78 3.72 2.95 3.44 3.15
Sodium (mmol/L) [135–150] 131 137 135 134 137 139
Potassium (mmol/L) [3.5–5.0] 4.5 5.4 5.3 4.7 4.1 3.9
Urea (mmol/L) [1.0–8.3] 7.9 18.2 29.7 26.4 29.8 19.6
Creatinine (µmol/L) [70–120] 116 275 405 425 512 346
Total bilirubin (mmol/L) [3–17] 46 44 39 35 25 17
Aspartate aminotrans-
ferase (U/L)
[12–37] 80 104 92 78 37 31
Alanine aminotransferase 
(U/L)
[20–65] 77 70 50 33 31 23
Alkaline phosphatase 
(U/L)
[50–136] 151 135 119 97 110 95
Lactate dehydrogenase 
(U/L)
[140–280] 994 2164 1680
Creatine kinase (U/L) [<170] 177 221
INR [0.8–1.2] 1.23 1.46 1.42 1.21 1.39 1.34
Prothrombin time (s) [11–14] 15.4 17.5 17.2 15.2 16.9 16.4
aPTT (s) [25–35] 44.3 55.9 51.0 54.8 59.9 47.6
NS1 antigen Positive
Dengue IgM Positive
CRP (mg/L) [<1] >200 >200 >200
Random blood sugar 
(mmol/L)
[6–10] 6.5 5.0 5.7 6.1 5.3 5.2
ABG FMO2 5 L/min CPAP FiO2 60% BIPAP FiO2 60% BIPAP FiO2 60% CPAP FiO2 40% NPO2 3 L/min
pH [7.5–7.45] 7.36 7.247 7.28 7.35 7.43 7.43
PaO2 (mmHg) [>80] 77.4 100 133 142 89.1 111
PaCO2 (mmHg) [35–45] 25.6 30.4 25.7 28.8 30.9 38
HCO3 (mmol/L) [22–26] 21.2 16.1 14.3 17.7 22 25.5
Lactate (mmol/L) [<2] 1.8 3.5 2.8 1.2 0.8 0.6
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following month, he was discharged from the medical 
clinic without serious complications.
Discussion
The first case of dengue-malaria dual infection was 
reported in France in 2005 [6] in which P. falciparum-
DENV co-infection was detected, followed by a few more 
case reports. One year later in 2006, cases on P. vivax-
DENV dual infection were reported [18, 19]. Although 
concurrent infection is uncommon, it has subsequently 
been mentioned with increasing frequency in literature. 
There were isolated case reports in India [7, 20–24], East 
Timor [12], Japan [17], Bangladesh [13], Indonesia [14], 
Malaysia [16], and Cambodia [15]. Following that, a 
series of cases were reported in French Guiana [25, 26], 
Brazil [11, 27], India [28–30], Bangladesh [31], Pakistan 
[10], Peru [32], and Kenya [33].
Studies were conducted regionally and it was noticed 
that the incidence of dual malaria-dengue co-infection 
among patients presented with acute febrile illness was 
actually higher than expected, ranging from 1 to 33% of 
the acute febrile illness state in different countries [8–10, 
26, 33]. This increase may be explained by the overlap 
of vectors in endemic areas and increased prevalence of 
dengue fever [9, 26].
Thailand has been one of the dengue and malaria out-
break regions in Southeast Asia [2, 34]. It is an impor-
tant country in malaria research because there have 
been reports on the artemisinin-resistant strain of falci-
parum malaria at the Thai–Cambodian border and the 
Greater Mekong Sub-region (Cambodia, Laos, Myan-
mar, Viet Nam) [2, 35, 36]. Surprisingly, in a study con-
ducted in Thailand in 2006 by Singhsilarak et al. involving 
194 patients with malaria, no co-infection with dengue 
was found [37]. To date, there has been only one case 
reported in Thailand on dual dengue-malaria infection 
involving P. falciparum-DENV [38]. With this current 
incidence occurring near the Malaysia–Thailand border, 
awareness among doctors in this region is crucial with 
regard to the possibility of co-infection. Both diseases 
are endemic in Southeast Asia, especially in areas near 
to jungle that is undergoing urbanization. As for Malay-
sia, both diseases may overlap in Sarawak and Sabah [39], 
Pahang and Kelantan [40].
Clinical presentations of P. falciparum-DENV co-
infections have been described over the past decade [6, 
12, 17], as well as that of P. vivax and DENV co-infection 
[10, 11, 18]. This is probably one of the first few reports 
of concurrent P. knowlesi-DENV dual infection. There 
have been two cases of P. knowlesi-DENV co-infection 
reported before [41, 42], but this article is the first with 
a detailed case scenario and description of the dangers if 
misdiagnosed.
Plasmodium knowlesi is one of the most common 
causes of malaria-related deaths in Malaysia [2, 43]. It 
was first detected in Malaysia in 1965 but faced diag-
nostic difficulty because of its similar morphology with 
Plasmodium malariae. Unfortunately, it gives a more 
severe clinical manifestation compared to P. malariae. 
It can be associated with high parasitaemia and, like P. 
falciparum, it can be fatal [41, 43, 44]. In view of the 
diagnostic difficulty and the high mortality risk, the 
Malaysian Malaria Management Guidelines recom-
mend that all blood film results with parasites resem-
bling P. malariae should be reported as P. knowlesi/P. 
malariae and patients should be treated as P. knowlesi 
infection [45].
Fig. 1 a Portable chest radiograph (AP view) looks normal on 
presentation to the emergency department (day 1); b chest radio-
graph repeated the following day showed the presence of perihilar 
haziness and increased pulmonary vascular markings (day 2); c chest 
radiograph showed increased air-space opacity in both lungs and 
parapneumonic effusion (day 6). AP anteroposterior
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Knowlesi malaria is a simian malaria which is unlike 
other types of malaria as it can be carried by Old World 
monkeys [46, 47]. The eradication of this parasitic dis-
ease is expected to be difficult and not achievable in the 
near future. The incidence of co-infection should be 
taken seriously. Reported cases of concurrent infection 
in Southeast Asia are far too few compared to the den-
gue-malaria co-infection rate, from 1 to 33%: in French 
Guiana (1%) [26], Kenya (5.7%) [33], India (10.25%) [8], 
and Pakistan (23.21–33%) [9, 10] in local studies. The 
actual number of incidences are probably underestimated 
as such areas are known to be highly endemic for both 
malaria and dengue, especially around the forest area of 
Myanmar, Thailand, Laos, Vietnam, East Timor, Papua, 
Sabah, and Sarawak.
Incidence of co-infection with dengue and malaria is 
likely to increase as today’s population is highly mobile, 
with increased activities brought about by good transpor-
tation systems. These two diseases share similar major 
symptoms such as fever, headache, myalgia, arthralgia, 
rash, nausea, diarrhoea, vomiting, and abdominal pain. 
Differentiating them is difficult on clinical grounds alone. 
One of the clinical signs that may suggest malaria rather 
than dengue in this context will be splenomegaly [48]. 
However, this patient had no splenomegaly and absence 
of splenomegaly does not rule out malaria. With the 
emergence of malaria-dengue co-infections, even with 
laboratory investigations, the risk of overlooking malaria 
is still high in dengue outbreak areas and vice versa. This 
is because they both share similar laboratory findings 
with dengue, such as thrombocytopaenia. In Malaysia, 
the confirmation tests for dengue (NS1 antigen and den-
gue IgM) are rapid and easily available. A positive con-
firmatory dengue test often misleads practitioners to rule 
out the possibilities of other diseases without actually 
screening against it [42, 49, 50].
The challenges for a reliable clinical diagnosis are fur-
ther increased with atypical manifestations of dengue 
fever in recent years. These include dengue encephalitis, 
dengue myocarditis, dengue with ARDS and pleural effu-
sion, dengue-induced hepatitis, and severe dengue caus-
ing kidney failure [51]. However, there are some signs for 
clinicians to suspect the presence of concomitant infec-
tion with dengue. Firstly, in most cases of dengue, the 
Fig. 2 Timeline of key events. Timeline in the diagnosis, treatment and progress of the patient with concomitant dengue and Plasmodium knowlesi 
malaria (upper part). Progress of parasite count and usage of antibiotics (lower part). ABG arterial blood gas, CR chest radiography FBC full blood 
count, ICU intensive care unit, NIV non-invasive ventilation, SPO2 oxygen saturation
Page 6 of 8Chong et al. Malar J  (2017) 16:2 
fever spikes by day 5 of illness. Fever may be prolonged in 
patients who have co-existing infections [52]. Secondly, 
patients with dengue are more likely to have a tempera-
ture under 39 °C [48]. Thirdly, they are more likely to be 
associated with leucopenia [48], haemo concentration [8] 
and atypical lymphocytosis [34, 35]. In this patient, the 
temperature was 40  °C on day 6 of illness, there was no 
haemoconcentration and no leucopenia. Additionally, he 
had anuria, worsening metabolic acidosis and hyperlac-
tatemia, which was resistant to aggressive fluid resusci-
tation. These are strong indications to further investigate 
co-existing infections. In fact, a leptospirosis test was 
taken on admission with prophylactic treatment for lep-
tospirosis. Unfortunately, BFMP was not done upon 
admission.
There is a scoring system based on clinical and labora-
tory criteria, described by Epelboin et al. [52], to predict 
the need for a parasitological examination in a febrile 
patient with atypical symptoms (Table  2). The patient 
scored 13/14 in this scoring upon admission and was 
indicated for a BFMP screening.
The most important lesson from this case report was 
that the delay in suspecting malaria infection caused a 
delay in treatment, which resulted in the deterioration 
of the patient’s condition. The history that the patient’s 
home was near the jungle should have prompted an early 
BFMP test but it was only when he developed uncor-
rected acidosis and the presence of shivering that this 
was done.
A timely diagnosis of malaria is of utmost importance 
because with early treatment the outcome is good. If 
left untreated, this condition can rapidly turn fatal as 
P. knowlesi has a 24-h replication cycle [53] (48 h for P. 
falciparum, P. vivax and P. ovale; 72  h for P. malariae 
[54]) which causes a drastic rise in parasitaemia lead-
ing to multiple organ failure. Additionally, treatment 
of these two illnesses differs. Most dengue cases can be 
treated with adequate supportive management, i.e., fluid 
replacement and other measures. Supportive manage-
ment itself may reduce the mortality rate from more than 
20% to less than 1% in severe dengue cases [55]. To treat 
malaria, specific anti-malarial medication has to be used 
or the infection may rapidly become fatal [56, 57]. In a 
case reported in East Timor, a girl who falsely tested neg-
ative for malaria with a rapid diagnostic kit died within 
7 h of admission because of delayed treatment [12]. There 
were several mortalities in Malaysia where parenteral 
artesunate was delayed because P. knowlesi was wrongly 
reported as P. malariae, which has a relatively benign 
clinical course [57]. Awareness and a high index of sus-
picion of the possibility of dengue-malaria co-infection 
can be life-saving and any suspicion of such case must be 
carefully excluded.
The severe manifestation of this patient may be mul-
tifactorial. Apart from the delay in diagnosis and treat-
ment, it can also be due to the co-infection of malaria 
and dengue which caused an exaggerated host immune 
response, as in the theory proposed by Mendonca et al. 
[58]. Concurrent infections have also been suggested to 
be more severe than isolated infection [25, 58]. How-
ever, this statement remains controversial. Halsey et  al. 
reported no difference in severity between isolated infec-
tion and co-infection [32].
Conclusion
This article aims to contribute to the body of knowl-
edge on the presentation, progress and management 
of P. knowlesi-DENV co-infection. This may aid simi-
lar encounters in future, especially in Southeast Asia 
where P. knowlesi abounds. The medical fraternity 
should be alert regarding the possibility of co-existing 
infection which may mimic the atypical presentations 
of dengue fever. Dengue mortality in Malaysia has been 
increasing [59], any emergence of undiagnosed con-
comitant malaria may worsen this situation. A high 
index of suspicion is of utmost importance to prevent 
deadly complications arising from delayed treatment. 
Further research is required to determine the real 
incidence in order to guide the management of acute 
febrile illness.
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Table 2 Scoring to  differentiate dengue monoinfection 
and dengue-malaria coinfection
Criteria fulfilled by the patient
1. Score <10: low risk of malaria
2. Score ≥10: Indication for parasite examination
Sensitivity of 0.997 (95% CI 0.995–1); specificity of 0.41 (95% CI 0.32–0.50)
Cited from: Epelboin et al. [52]
Criteria towards dengue Score
Male gender 1
C-reactive protein >5 mg/L 9
Age >15 years old 1
Platelet count <100.109/L 2
Haematocrit <36% 1
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